Regeneron Pharmaceuticals, Inc. (REGN)


Regeneron Pharmaceuticals, Inc. (REGN)

$296.85 USD

3.74 (1.28%)

Updated Aug 16 12:00am

Add REGN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

REGN Daily Price Range
REGN 52-Week Price Range

REGN Stock Chart More Charts


REGN Price/Volume Stats

Current price $296.85
Prev. close $293.11
Day low $290.72
Day high $297.35
50-day MA $305.62
200-day MA $357.39
52-week high $442.00
52-week low $287.66
Volume 742,500
Avg. volume 792,554
Dividend yield N/A
Market Cap 32.60B

Regeneron Pharmaceuticals, Inc. (REGN) Company Bio


Regeneron Pharmaceuticals is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, and atopic dermatitis. The company was founded in 1988 and is based in Tarrytown, New York.





REGN News Stream


Event/Time News Detail
Loading, please wait...

REGN Social Stream


Loading social stream, please wait...

View Full REGN Social Stream

REGN Returns

1-mo -0.42%
3-mo -4.23%
6-mo -29.74%
1-year -20.68%
3-year -26.58%
5-year -14.03%
YTD -20.52%
2018 -0.65%
2017 2.42%
2016 -32.38%
2015 32.33%
2014 49.05%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4394 seconds.